Oncology PracticeBevacizumab Halves Progression Risk in Recurrent Ovarian CancerJune 5, 2011Gynecologic Cancer
Oncology PracticeScreening Does Not Reduce Ovarian Cancer MortalityJune 4, 2011Preventive CareGynecologic Cancer
Oncology PracticeAntiviral Cidofovir May Enhance Therapies for HPV-Related Cancers May 25, 2011Gynecologic Cancer
Oncology PracticePARP Inhibitor Olaparib Delays Progression in Ovarian CancerMay 18, 2011Gynecologic Cancer
Oncology PracticeThree-Year Interval Safe for Cervical Cancer Screening after Negative HPV TestMay 18, 2011Gynecologic Cancer
Oncology PracticeGynecologic Cancer Symptoms May Be More Severe in Women With Psychiatric HistoriesApril 14, 2011Gynecologic CancerPatient & Survivor Care
Oncology PracticeBRCA2 Gene Mutation Linked With Improved Survival in Ovarian Cancer April 11, 2011Gynecologic Cancer
Oncology PracticeFewer Than Half of Ovarian Cancer Patients Get Care Consistent with NCCN GuidelinesApril 6, 2011Gynecologic CancerPatient & Survivor Care
The Journal of Community and Supportive OncologySymptom Experience in Patients with Gynecological Cancers: The Development of Symptom Clusters through Patient NarrativesApril 2, 2011Gynecologic Cancer
Oncology PracticeHalf of HIV+ Women in Zambia Positive for Cervical CancerMarch 14, 2011Preventive CareGynecologic Cancer
Oncology PracticeBevacizumab Doubles Risk of GI Adverse Events in Key Ovarian Cancer Trial March 10, 2011Patient & Survivor CareGynecologic Cancer
Oncology PracticeOptimal Therapy Elusive for Many Ovarian Cancer Patients With MedicareMarch 7, 2011Gynecologic Cancer
The Journal of Community and Supportive OncologyPilot Study of the Prospective Identification of Changes in Cognitive Function During Chemotherapy Treatment for Advanced Ovarian Cancer January 25, 2011Gynecologic CancerPatient & Survivor Care
